SCHEMBL7194398

SCHEMBL7194398

Cc1c(O)ccc2c(O)c(N=Nc3ccccc3)c(=O)oc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 13/20 0.56
▸ ESR1 P03372 9/20 0.54
▸ SHBG P04278 1/20 0.51
▸ KDM4E B2RXH2 4/20 0.49
▸ GAA P10253 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ CA12 O43570 1/20 0.47
▸ TNF P01375 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ NOD2 Q9HC29 1/20 0.47
▸ NOD1 Q9Y239 1/20 0.47
▸ MAPK1 P28482 3/20 0.46
▸ GLA P06280 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ MAOA P21397 1/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ CASP7 P55210 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ MAPT P10636 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6933964 1.00 ESR2 (0.56) ESR2ESR1SHBGKDM4EGAA
SCHEMBL11766670 0.75 MAPT (0.59) KDM4EALDH1A1SMN1; SMN2CA12CA9
SCHEMBL11766676 0.75 MAPT (0.59) KDM4EALDH1A1SMN1; SMN2CA12CA9
SCHEMBL6931580 0.73 NQO1 (0.54) ESR2ESR1KDM4EGAAALDH1A1
SCHEMBL6825266 0.72 ESR2 (1.00) ESR2ESR1SHBGKDM4EGAA
SCHEMBL9642463 0.72 MAPT (0.60) KDM4EGAAALDH1A1CA12TNF
SCHEMBL9642459 0.72 MAPT (0.60) KDM4EGAAALDH1A1CA12TNF
SCHEMBL3766383 0.71 KDM4E (0.74) ESR2ESR1SHBGKDM4EGAA
SCHEMBL15413701 0.71 ESR2 (0.62) ESR2ESR1KDM4EGAAALDH1A1
SCHEMBL18073978 0.71 ESR2 (0.63) ESR2ESR1SHBGKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1213055-C Novel ribose-substituted aromatic amides, method for prodn. and use thereof as medicaments AVENTIS PHARMA SA (FR) 2005-08-03 — — CN disclosed
US-6579902-B1 Antibiotic; ethoxy-carbamic acid 3'-ester of N-(7-((6-deoxy-5-C-methyl-4-O- methyl-alpha-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1 -benzopyran-3-yl)-benzeneacetamide AVENTIS PHARMA S.A. (FR) 2003-06-17 — — US disclosed
EP-1173455-A2 NOVEL RIBOSE-SUBSTITUTED AROMATIC AMIDES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma S.A. (FR) 2002-01-23 — — EP disclosed
WO-2000063222-A2 NOVEL RIBOSE-SUBSTITUTED AROMATIC AMIDES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA S.A. (FR) 2000-10-26 — — WO disclosed
Send feedback